论文部分内容阅读
目的:观察尼莫地平辅助治疗脑出血的疗效和安全性。方法:选取100例脑出血患者,随机分为两组,对照组采用常规治疗,观察组在常规治疗的基础上加用尼莫地平治疗。结果:观察组50例,有效43例,总有效率86%;对照组50例,有效34例,总有效率68%,两组总有效率的差异有统计学意义(P<0.05)。观察组4例患者出现头晕、面色潮红,对照组发生上消化道出血2例,均经处理后好转。结论:尼莫地平在脑出血的治疗中安全有效,值得推广。
Objective: To observe the efficacy and safety of nimodipine in the treatment of cerebral hemorrhage. Methods: One hundred patients with cerebral hemorrhage were selected and randomly divided into two groups. The control group was treated with conventional therapy. The observation group was treated with nimodipine on the basis of routine treatment. Results: The observation group of 50 cases, effective in 43 cases, the total effective rate of 86%; control group of 50 cases, 34 cases of effective, the total effective rate was 68%. There was significant difference between the two groups total effective rate (P <0.05). In the observation group, 4 patients developed dizziness, flushing, and 2 cases of upper gastrointestinal bleeding in the control group, all of which were improved after treatment. Conclusion: Nimodipine is safe and effective in the treatment of intracerebral hemorrhage and is worth promoting.